# Trypanosoma cruzi (DTU TcI) in a fatal case of meningoencephalitis due to Chagas disease reactivation in a patient coinfected with human immunodeficiency virus: case report

**Authors:** Hevillyn Fernanda Lucas da Silva, Luís Fernando Fernandes Miranda, Matheus da Silva de Oliveira, Pedro Paulo Gilio Saraiva, Rafael Zanutto Nakata, Rodrigo Pernomian Cianca, Rúbia Pazzetto, Cesar Helbel, Amanda Regina Nichi de Sá, Cristiane Maria Colli, Max Jean de Ornelas Toledo

PMC · DOI: 10.1590/0037-8682-0234-2024 · Revista da Sociedade Brasileira de Medicina Tropical · 2025-10-03

## TL;DR

A man with HIV in Brazil died from meningoencephalitis caused by reactivated Chagas disease, likely due to a specific strain of Trypanosoma cruzi.

## Contribution

This case report highlights the fatal outcome of meningoencephalitis due to TcI strain reactivation in an HIV-coinfected patient.

## Key findings

- T. cruzi trypomastigotes were detected in cerebrospinal fluid and blood.
- The TcI DTU was confirmed through cytochrome oxidase II sequencing.
- The patient's death was attributed to delayed treatment, severe immunosuppression, and TcI involvement.

## Abstract

The reactivation of Chagas disease (RCD) by human immunodeficiency virus (HIV) is associated with high mortality and is a relevant public health problem in areas endemic for the causative agent of CD, Trypanosoma cruzi (T. cruzi). Here, we report a fatal case of meningoencephalitis caused by RCD involving the discrete typing unit (DTU) of T. cruzi I (TcI) in an HIV-coinfected patient from Paraná, Brazil. Based on computed tomography findings, a 55-year-old man initially underwent empirical treatment for neurotoxoplasmosis. However, Giemsa-stained cerebrospinal fluid and blood smears revealed T. cruzi trypomastigotes on direct microscopic examination. Protozoa were detected by fresh blood examination and blood culture. Additionally, anti-T. cruzi immunoglobulin G antibodies were detected in serum using a chemiluminescent immunoassay. Blood culture sequencing of cytochrome oxidase II confirmed the DTU TcI infection. Benznidazole therapy was administered for 76 d; however, the patient showed no clinical improvement and died nearly 7 months after hospital admission. The fatal outcome was likely related to delayed diagnosis and treatment, severe immunosuppression (CD4 = 39 cells/mm³), high viral load (94,638 copies/mL), and the involvement of TcI, which has been consistently associated with fatal RCD-related meningoencephalitis.

## Linked entities

- **Chemicals:** Benznidazole (PubChem CID 31593)
- **Diseases:** Chagas disease (MONDO:0001444), meningoencephalitis (MONDO:0005845)
- **Species:** Trypanosoma cruzi (taxon 5693)

## Full-text entities

- **Diseases:** meningoencephalitis (MESH:D008590), HIV-coinfected (MESH:D060085), Chagas disease (MESH:D014355), neurotoxoplasmosis (MESH:D016781), CD (MESH:D003424)
- **Chemicals:** Benznidazole (MESH:C009999)
- **Species:** Human immunodeficiency virus (species) [taxon 12721], Trypanosoma cruzi (species) [taxon 5693], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12578319/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12578319/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12578319/full.md

---
Source: https://tomesphere.com/paper/PMC12578319